Details For Selected Brain Tumor Treatment

Sponsored By

Cedars-Siani Medical Center Brain Tumor Program

Please Click On The Above Banner For More Details

Back to New Treatments List


		Treatment Name:		Phase II Trial of Sunitinib (SU011248) in Patients With Recurrent or Inoperable Meningioma

		Phase:		Phase 2

		Treatment ID#:		1887

		Age Group:		Adults Only

		Min Karnofsky Score:		60: Requires occasional assistance but is able to care for most of own needs

		Conditions:		Prior Surgery is Allowed Prior Radiation is Allowed Prior Chemotherapy is Allowed

		Last Updated:		10/09/2008

		Tumor Types:		Meningioma


		Comments:

		Treatment Type:		Less-Toxics

		Contact:		Frank Lieberman MD U. of Pittsburgh Medical Center Contact: Melissa Clark 5115 Centre Avenue Pittsburgh, PA 15232 USA Phone: 412-647-9578 Fax: E-mail: clarkml2@upmc.edu Website: www.upmccancercenters.com/brain/treated.cfm

Last updated refers to the date when our listing for each treatment was last updated.
ID is a combination of our internal ID and the official ID for the trial, if any.
Min Karnofsky is a general guide to how well you have to function to use this treatment

Translate this pageMicrosoftÂ® Translator

Copyright (c) 1993 - 2009 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740

Website Design By